SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 10.50
0.00 (0.00%)
Jul 6, 2026, 4:00 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 27.21 million as of July 6, 2026. Its market cap has decreased by -50.30% in one year.
Market Cap
27.21M
Enterprise Value
25.03M
Revenue
5.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.50
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 27.21M, an increase of 73.01%. That is a compound annual growth rate of 6.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 27.21M | -33.23% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemogenyx Pharmaceuticals | 52.36M |
| hVIVO | 48.78M |
| Poolbeg Pharma | 47.59M |
| Sareum Holdings | 29.10M |
| Arecor Therapeutics | 23.98M |
| ImmuPharma | 20.78M |
| IXICO | 17.99M |
| Aptamer Group | 16.41M |